The phosphorylation of eIF2alpha is usually considered pathological in neurodegenerative conditions52–54 and its pharmacological or genetic inhibition has been shown to protect animal models of frontotemporal dementia55 and Alzheimer's disease.54 The gene discussed is EIF2S1; the disease is early-onset autosomal dominant Alzheimer disease.